U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 010418

Expand all

XYLOCAINE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
0.005MG/ML;1%
Marketing Status: Discontinued
Active Ingredient: EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Proprietary Name: XYLOCAINE W/ EPINEPHRINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.005MG/ML;1%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010418
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
XYLOCAINE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
0.005MG/ML;1.5%
Marketing Status: Discontinued
Active Ingredient: EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Proprietary Name: XYLOCAINE W/ EPINEPHRINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.005MG/ML;1.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010418
Product Number: 010
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
XYLOCAINE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
0.005MG/ML;2%
Marketing Status: Discontinued
Active Ingredient: EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Proprietary Name: XYLOCAINE W/ EPINEPHRINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.005MG/ML;2%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010418
Product Number: 008
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
XYLOCAINE (LIDOCAINE HYDROCHLORIDE)
1%
Marketing Status: Discontinued
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: XYLOCAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010418
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
XYLOCAINE (LIDOCAINE HYDROCHLORIDE)
1.5%
Marketing Status: Discontinued
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: XYLOCAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010418
Product Number: 009
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
XYLOCAINE (LIDOCAINE HYDROCHLORIDE)
2%
Marketing Status: Discontinued
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: XYLOCAINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010418
Product Number: 007
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top